75 related articles for article (PubMed ID: 7867017)
1. The expression of HLA class I antigen in prostate cancer in relation to tumor differentiation and patient survival.
Levin I; Klein T; Kuperman O; Segal S; Shapira J; Gal R; Hart Y; Klein B
Cancer Detect Prev; 1994; 18(6):443-5. PubMed ID: 7867017
[TBL] [Abstract][Full Text] [Related]
2. Variation of HLA-ABC surface antigen expression on adenocarcinoma of the colon in correlation with the degree of differentiation.
Eyal A; Levin I; Segal S; Levi I; Klein B; Kuperman O
Nat Immun Cell Growth Regul; 1990; 9(3):222-7. PubMed ID: 2370880
[TBL] [Abstract][Full Text] [Related]
3. Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer.
Alberti I; Barboro P; Barbesino M; Sanna P; Pisciotta L; Parodi S; Nicolò G; Boccardo F; Galli S; Patrone E; Balbi C
J Cell Biochem; 2000 Sep; 79(3):471-85. PubMed ID: 10972984
[TBL] [Abstract][Full Text] [Related]
4. HLA class I antigen expression in human solid tumors.
Klein B; Levin I; Klein T
Isr J Med Sci; 1996 Dec; 32(12):1238-43. PubMed ID: 9007163
[TBL] [Abstract][Full Text] [Related]
5. Loss of HLA class I expression in prostate cancer: implications for immunotherapy.
Blades RA; Keating PJ; McWilliam LJ; George NJ; Stern PL
Urology; 1995 Nov; 46(5):681-6; discussion 686-7. PubMed ID: 7495121
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma.
Langat DK; Sue Platt J; Tawfik O; Fazleabas AT; Hunt JS
J Reprod Immunol; 2006 Aug; 71(1):75-86. PubMed ID: 16616377
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of HNK-1 (Leu-7) antigen in prostate cancer and its clinical significance.
Liu X; Zhan B; Tomoyoshi T; Masanori T
Chin Med J (Engl); 1995 Jul; 108(7):516-21. PubMed ID: 7555270
[TBL] [Abstract][Full Text] [Related]
8. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
[TBL] [Abstract][Full Text] [Related]
9. HLA expression in choroidal melanomas: correlation with clinicopathological features.
Krishnakumar S; Abhyankar D; Lakshmi SA; Pushparaj V; Shanmugam MP; Biswas J
Curr Eye Res; 2004 Jun; 28(6):409-16. PubMed ID: 15512948
[TBL] [Abstract][Full Text] [Related]
10. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I
Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178
[TBL] [Abstract][Full Text] [Related]
12. Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer.
Aaltomaa S; Lipponen P; Vesalainen S; Ala-Opas M; Eskelinen M; Syrjänen K
Eur Urol; 1997; 32(4):410-5. PubMed ID: 9412797
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
14. CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.
Kristiansen G; Pilarsky C; Pervan J; Stürzebecher B; Stephan C; Jung K; Loening S; Rosenthal A; Dietel M
Prostate; 2004 Feb; 58(2):183-92. PubMed ID: 14716744
[TBL] [Abstract][Full Text] [Related]
15. Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.
Xu C; Jung M; Burkhardt M; Stephan C; Schnorr D; Loening S; Jung K; Dietel M; Kristiansen G
Prostate; 2005 Feb; 62(3):224-32. PubMed ID: 15389793
[TBL] [Abstract][Full Text] [Related]
16. HLA-A, -B, -C expression in colon carcinoma mimics that of the normal colonic mucosa and is prognostically relevant.
Benevolo M; Mottolese M; Piperno G; Sperduti I; Cione A; Sibilio L; Martayan A; Donnorso RP; Cosimelli M; Giacomini P
Am J Surg Pathol; 2007 Jan; 31(1):76-84. PubMed ID: 17197922
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of HLA class I heavy chain expression in patients with gastric cancer.
Ueda Y; Ishikawa K; Shiraishi N; Yokoyama S; Kitano S
J Surg Oncol; 2008 Apr; 97(5):451-5. PubMed ID: 18247377
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma.
Weinman EC; Roche PC; Kasperbauer JL; Cha SS; Sargent DJ; Cheville J; Murphy LM; Chen L; Wettstein PJ; Gostout B; Ferrone S; Strome SE
Cancer; 2003 May; 97(9):2203-11. PubMed ID: 12712472
[TBL] [Abstract][Full Text] [Related]
19. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin.
Xing N; Qian J; Bostwick D; Bergstralh E; Young CY
Prostate; 2001 Jun; 48(1):7-15. PubMed ID: 11391682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]